Close
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study Jun 2, 2024 10:55AM

Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects

REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma... (continue reading...)


Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Jun 2, 2024 10:00AM
  • HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancers
  • ER status was accurately assessed and the level of ER pathway activation quantified in 87 patients with advanced breast cancer
  • Results support the relevance of the Precede Bio platform to the more than 70 therapeutics directly targeting HER2 and the ER pathway in active clinical development

BOSTON, June 02, 2024 (GLOBE NEWSWIRE) -- Precede Biosciences, a... (continue reading...)


ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer Jun 2, 2024 10:00AM
  • Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate (“ADC”), demonstrated promising activity and was generally well tolerated
  • Company to host conference call and webcast with Samuel A. Funt, M.D., of Memorial Sloan Kettering Cancer Center on Friday, June 7, 2024, at 1:00 PM ET

SOUTH SAN FRANCISCO, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an... (continue reading...)


Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 The Jun 2, 2024 10:00AM
  • Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line treatment
  • 48% ORR in evaluable anti-PD-1 naïve patients (n=25); 28% ORR in evaluable anti-PD-1 resistant patients (n=25) as per RECIST 1.1
  • 76% DCR in evaluable naïve patients; 68% DCR in evaluable resistant patients as per RECIST 1.1
  • Preliminary review of... (continue reading...)

BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Jun 2, 2024 09:51AM

SAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Biogen Inc. (NASDAQ: BIIB) securities between February 3, 2022 and February 13, 2024, both dates inclusive (the “Class Period”), have until July 22, 2024 to seek appointment as lead plaintiff in the Biogen class action lawsuit. Captioned Gray v. Biogen Inc., No. 24-cv-01444 (D. Colo.), the Biogen class action lawsuit charges Biogen as well as... (continue reading...)


More Globe Newswire

View Older Stories

Jun 2, 2024 09:01AM Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024
Jun 2, 2024 08:56AM NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan
Jun 2, 2024 08:52AM NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autonomous Machines
Jun 2, 2024 08:44AM Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omniverse
Jun 2, 2024 08:41AM NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs
Jun 2, 2024 08:35AM Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
Jun 2, 2024 08:32AM NVIDIA Supercharges Ethernet Networking for Generative AI
Jun 2, 2024 08:23AM GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Jun 2, 2024 08:13AM NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
Jun 2, 2024 08:11AM NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
Jun 2, 2024 08:00AM Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
Jun 2, 2024 08:00AM William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
Jun 2, 2024 08:00AM CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
Jun 2, 2024 04:00AM BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
Jun 2, 2024 02:00AM ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
Jun 1, 2024 09:00PM BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
Jun 1, 2024 08:15PM Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
Jun 1, 2024 05:10PM National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
Jun 1, 2024 03:00PM First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
Jun 1, 2024 01:02PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
Jun 1, 2024 12:55PM Union members and allies mark Injured Workers’ Day in locations across Ontario
Jun 1, 2024 12:36PM Prospera Energy Inc. Announces 2023 Financial Results
Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 08:05AM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00AM CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
Jun 1, 2024 08:00AM Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
Jun 1, 2024 08:00AM Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
Jun 1, 2024 08:00AM OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
Jun 1, 2024 08:00AM Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
Jun 1, 2024 08:00AM Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
Jun 1, 2024 07:55AM ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 07:00AM Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
Jun 1, 2024 05:42AM VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
Jun 1, 2024 05:41AM SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigation into the $44 Buyout Offer
Jun 1, 2024 05:39AM SPT (NYSE) FRAUD ALERT: Sprout Social, Inc. Investors who Lost Money when Stock Plummeted 40% are Encouraged to Contact BFA Law about Upcoming Deadline
Jun 1, 2024 05:37AM PATH (NYSE) INVESTOR ALERT: UiPath, Inc. Investigated for Securities Fraud After 34% Stock Drop, Contact BFA Law if You Suffered Losses
Jun 1, 2024 05:36AM CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
Jun 1, 2024 05:34AM CAE (NYSE) INVESTOR ALERT: CAE, Inc. Investigated for Securities Fraud from Impairment Charges, Contact BFA Law if You Suffered Losses
Jun 1, 2024 05:33AM BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law about Upcoming Legal Deadline
Jun 1, 2024 05:30AM NIO Inc. Provides May 2024 Delivery Update
Jun 1, 2024 05:00AM XPENG Announces Vehicle Delivery Results for May 2024
Jun 1, 2024 03:23AM Subsea7 awarded four PLSV contracts in Brazil
View Older Stories